Quantumzyme Corp. Proposes Name Change to Quantum Genesis AI Corp. to Reflect AI Integration in Enzyme Engineering
Quantumzyme Corp., a biotransformation company developing enzyme-based pharmaceutical manufacturing solutions, announced its Board of Directors has approved a proposed corporate name change to Quantum...
Biohacking Index November 2025 Report Highlights Top Wellness Brands Based on Verified Community Reviews
Wellness Eternal has released the November 2025 Biohacking Index Report, showcasing the top ten wellness and longevity brands ranked solely by verified five-star reviews submitted in or before Novembe...
Study Reveals Mirror-Image Pesticide Forms Differ in Accumulation and Harm Across Fish Generations
A new study published in Environmental Chemistry and Ecotoxicology has revealed significant differences in how mirror-image forms of a persistent pesticide metabolite behave when transferring from mot...
NPI Promotes Scott Gould to Vice President, Strengthening Fourth-Generation Leadership and Modern Operations
Nutritional Products International Announces Key Promotion as Gould Family’s Century-Long Retail Heritage Continues.
Tropical Oasis Appoints Surgeon Dr. Lauren Ramsey as Clinical Ambassador to Strengthen Scientific Foundation
Tropical Oasis announced the appointment of Dr. Lauren Ramsey, a board-certified surgeon and medical researcher, as Clinical Ambassador in a move that strengthens the brand's science-first mission. Th...
AI-Driven Smart Knee Sleeve Shows Promise in Preventing ACL Injuries Through Micro-Airbag Technology
Hippos Exoskeleton has developed an AI-driven ultra-light smart knee sleeve that deploys a micro-airbag to stabilize the knee in under 50 milliseconds. Recent testing at Cleveland Clinic's BioRobotics...
Nutriband Chairman to Present at NobleCon21, Highlighting Abuse-Deterrent Transdermal Technology
Nutriband Inc. has announced that Chairman and Co-Founder Serguei Melnik will present at NobleCon21, Noble Capital Markets' annual emerging growth equity conference. The presentation is scheduled for ...
ORGANA International Expands National Reach with Walmart.com Partnership
ORGANA International, the natural wellness brand known for its mineral-rich, bioavailable formulations, is now available on Walmart.com, giving millions of U.S. consumers convenient access to its eart...
SEGG Media Surpasses 45 Million Live-Stream Views on Sports.com Platform
SEGG Media Corporation has surpassed 45 million cumulative live-stream views on its Sports.com platform, demonstrating the growing appeal of live competition content in an entertainment landscape domi...
ABVC BioPharma Receives Additional Payment in Vitargus Licensing Agreement, Highlighting Market Potential
ABVC BioPharma has received an additional $250,000 payment from ForSeeCon Eye Corporation under their existing ophthalmic medical device licensing agreement, bringing total payments received to $816,0...
Creative Biolabs Enhances mRNA Platform with Integrated Design, Delivery, and Validation Capabilities
Creative Biolabs has announced a significant upgrade to its mRNA technology platform, offering an integrated end-to-end solution that spans design, delivery, and functional validation. The enhanced pl...
MED Holdings Acquires TotalBody.com to Expand Digital Wellness Ecosystem
MED Holdings Group Inc. has announced the acquisition of TotalBody.com, a telehealth platform designed to deliver comprehensive wellness, weight loss, hormone therapy, and longevity medicine programs ...
MEGASTAR Launches T35 All-in-One Strength Training System for Home Gyms
MEGASTAR has announced the T35 All-in-One Strength Training System, a comprehensive strength training solution that integrates a power cage, Smith machine, and cable crossover into a single unit. The ...
MEGASTAR Launches W59 Multi-Function Adjustable Weight Bench for Home Gyms
MEGASTAR has launched the W59 Multi-Function Adjustable Weight Bench, featuring a comprehensive adjustment system and integrated training stations designed specifically for home and garage gym environ...
Annovis Bio Secures FDA Meeting for Parkinson's Dementia Drug Development
Annovis Bio Inc. has secured a Type C meeting with the U.S. Food and Drug Administration scheduled for January 2026 to discuss the clinical pathway for buntanetap in Parkinson's disease dementia. The ...
Annovis Bio's Buntanetap Shows Promise in Halting Cognitive Decline in Parkinson's Patients with Alzheimer's Co-pathology
Annovis Bio Inc. released new findings from its Phase 3 early Parkinson's disease study demonstrating that buntanetap halted cognitive decline across all patients and delivered the strongest benefit i...
CNS Pharmaceuticals Reports Progress on Blood-Brain Barrier Drug Candidate for Glioblastoma
CNS Pharmaceuticals Inc. has reported third-quarter 2025 financial results while highlighting significant progress with its lead drug candidate TPI 287, a blood-brain barrier-permeable abeotaxane bein...
NRx Pharmaceuticals Reports Q3 2025 Progress in Suicidal Depression Treatments
NRx Pharmaceuticals, Inc. reported third-quarter 2025 results while highlighting substantial progress across its clinical pipeline, particularly for treatments targeting suicidal depression. The compa...
NanoViricides Reports Progress on Broad-Spectrum Antiviral NV-387 in Quarterly Filing
NanoViricides, Inc. has filed its Form 10-Q for the quarter ended September 30, 2025, highlighting significant progress on its lead drug candidate NV-387, a first-in-class broad-spectrum antiviral des...
GLP-1 Medications Show 50% Lower Mortality in Colon Cancer Patients, Study Finds
Recent research from UC San Diego revealed that colon cancer patients using GLP-1 medications such as Ozempic and Wegovy demonstrated a 50% lower mortality rate compared to those not taking these drug...